Rational design of potent sialidase-based inhibitors of influenza virus replication

von Itzstein, Mark, Wu, Wen-Yang, Kok, Gaik B., Pegg, Michael S., Dyason, Jeffrey C., Jin, Betty, Van Phan, Tho, Smythe, Mark L. +10 more·1993·Nature

DOI 10.1038/363418a0

Cited by (1,001)

Items 401–500 of 1,001

Discovery and design of carbohydrate-based therapeutics
Laura Cipolla, Ana Catarina Araújo, Davide Bini, Luca Gabrielli, Laura Russo, Nasrin I. Shaikh · 2010 · Expert Opinion on Drug Discovery
Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives
Jae Min Song, Ki Duk Park, Kwang Hee Lee, Young Ho Byun, Ju Hee Park, Sung‐Han Kim, Jae‐Hong Kim, Baik Lin Seong · 2007 · Antiviral Research
Recent synthetic approaches to oseltamivir phosphate (Tamiflu™) for the treatment of influenza
Javier Magano · 2011 · Tetrahedron
Structural Studies of the β-Glycosidase from Sulfolobus solfataricus in Complex with Covalently and Noncovalently Bound Inhibitors
T.M. Gloster, Shirley M. Roberts, Valerie M.-A. Ducros, Giuseppe Perugino, Mosé Rossi, Roland Hoos, Marco Moracci, Andrea T. Vasella, G.J. Davies · 2004 · Biochemistry
The role and application of bioinformatics techniques and tools in drug discovery
Shujun Zhang, Kaijie Liu, Yafeng Liu, Xinjun Hu, Xinyu Gu · 2025 · Frontiers in Pharmacology
A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus
Maria Ekblad, Beata Adamiak, Tomas B. Bergström, Ken D. Johnstone, Tomislav Karoli, Ligong Liu, Vito Ferro, Edward Trybala · 2010 · Antiviral Research
Principles for 3D/4D QSAR classification of drugs
Vladimir Potemkin, Maria Grishina · 2008 · Drug Discovery Today
An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses
C.-T. Guo, Xue‐Long Sun, Osamu Kanie, K. F. Shortridge, Takuji Suzuki, D.T. Miyamoto, Kazuya I.P.J. Hidari, Chi‐Huey Wong, Yasuo Suzuki · 2002 · Glycobiology
Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors
Yu Liu, Fanbo Jing, Yingying Xu, Yuanchao Xie, Fangyuan Shi, Hao Fang, Minyong Li, Wenfang Xu · 2011 · Bioorganic & Medicinal Chemistry
Inhibition of Influenza Virus Infections by Sialylgalactose-Binding Peptides Selected from a Phage Library
Teruhiko Matsubara, Machiko Sumi, Hiroyuki Kubota, Takao Taki, Yoshio Okahata, Toshinori Sato · 2009 · Journal of Medicinal Chemistry
Origins of Resistance Conferred by the R292K Neuraminidase Mutation via Molecular Dynamics and Free Energy Calculations
Ricky Chachra, Robert C. Rizzo · 2008 · Journal of Chemical Theory and Computation
Synthesis and anti-Influenza virus activity of 7-O-Alkylated derivatives related to zanamivir
Takeshi Honda, Takeshi Masuda, Shuku Yoshida, Masami Arai, Satoru Kaneko, Makoto Yamashita · 2002 · Bioorganic & Medicinal Chemistry Letters
Selective Inhibitors of Human Neuraminidase 3
Tianlin Guo, Philipp Dätwyler, Ekaterina P. Demina, Michele R. Richards, Peng Ge, Chunxia Zou, Ruixiang Blake Zheng, Anne Fougerat, Alexey V. Pshezhetsky, Beat Ernst et al. · 2018 · Journal of Medicinal Chemistry
Three‐Step Synthesis of Sialic Acids and Derivatives
Zhangyong Hong, Lei Liu, Che‐Chang Hsu, Chi‐Huey Wong · 2006 · Angewandte Chemie International Edition
Identification of a novel HA conformational change inhibitor of human influenza virus
Jun Yoshimoto, Mayumi Kakui, Hiroko Iwasaki, Tamio Fujiwara, H. Sugimoto, N. Hattori · 1999 · Archives of Virology
Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs
Enguang Feng, Deju Ye, Jian Li, Dengyou Zhang, Jinfang Wang, Fei Zhao, Rolf Hilgenfeld, Mingyue Zheng, Hualiang Jiang, Hong Shu Liu · 2012 · ChemMedChem
Synthesis and anti-Influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives
Takeshi Honda, Shuku Yoshida, Masami Arai, Takeshi Masuda, Makoto Yamashita · 2002 · Bioorganic & Medicinal Chemistry Letters
Why is sialic acid attracting interest now? complete enzymatic synthesis of sialic acid with N-acylglucosamine 2-epimerase
Isafumi Maru, Jun Ohnishi, Yasuhiro Ohta, Yoji Tsukada · 2002 · Journal of Bioscience and Bioengineering
Antivirals Targeting the Neuraminidase
Larisa V. Gubareva, Teena Mohan · 2020 · Cold Spring Harbor Perspectives in Medicine
Quantum mechanics implementation in drug-design workflows: does it really help?
Olayide A Arodola, Mahmoud E. S. Soliman · 2017 · Drug Design Development and Therapy
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
Pooran Chand, Shanta Bantia, Pravin L. Kotian, Yahya A. El-Kattan, Tsu‐Hsing Lin, Yarlagadda S. Babu · 2005 · Bioorganic & Medicinal Chemistry
A New Route to Diverse 1-Azasugars fromN-Boc-5-hydroxy-3-piperidene as a Common Building Block
Hidekazu Ouchi, Yukiko Mihara, Hiroki Takahata · 2005 · The Journal of Organic Chemistry
Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors
Areej Abuhammad, Mutasem O. Taha · 2009 · Journal of Chemical Information and Modeling
Viral enzymes containing magnesium: Metal binding as a successful strategy in drug design
Dominga Rogolino, Mauro Carcelli, Mario Sechi, Nouri Neamati · 2012 · Coordination Chemistry Reviews
ParCrys: a Parzen window density estimation approach to protein crystallization propensity prediction
Ian M. Overton, Gianandrea Padovani, Mark Girolami, Geoffrey J. Barton · 2008 · Bioinformatics
Drug Design Workshop: A Web-Based Educational Tool To Introduce Computer-Aided Drug Design to the General Public
Antoine Daina, Marie-Claude Blatter, Vivienne Baillie Gerritsen, Patricia M. Palagi, Diana Marek, Ioannis Xénarios, Torsten F. Schwede, Olivier Alain Michielin, Vincent Zoete · 2017 · Journal of Chemical Education
Initial Events in Infectious Salmon Anemia Virus Infection: Evidence for the Requirement of a Low-pH Step
Trygve Meum Eliassen, Marianne K. Frøystad, Birgit Helene Dannevig, M. Jankowska, Andreas Brech, Knut Falk, Kristine Romøren, Tor Gjøen · 2000 · Journal of Virology
Antiviral chemotherapeutic agents against respiratory viruses
Megan J. Brooks, Joseph Sasadeusz, Gregory A. Tannock · 2004 · Current Opinion in Pulmonary Medicine
Sialidase Inhibitors with Different Mechanisms
Joseph M. Keil, Garrett R. Rafn, Isaac M. Turan, Majdi A. Aljohani, Reza Sahebjam-Atabaki, Xue‐Long Sun · 2022 · Journal of Medicinal Chemistry
A Novel Small-Molecule Inhibitor of the Avian Influenza H5N1 Virus Determined through Computational Screening against the Neuraminidase
Jianghong An, Davy C. W. Lee, Anna H.Y. Law, Cindy Lai-Hung Yang, Leo L. M. Poon, Allan S. Y. Lau, Steven J.M. Jones · 2009 · Journal of Medicinal Chemistry
Glucosyl Hesperidin Prevents Influenza A Virus Replication in Vitro by Inhibition of Viral Sialidase
Repon Kumer Saha, Tadanobu Takahashi, Takashi Suzuki · 2009 · Biological and Pharmaceutical Bulletin
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant
Jian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, Chiara Bertagnin, Huamei Lu, Xiujie Kong, Han Ju, Xueyi Lu, Ping Gao, Ye Edward Tian et al. · 2018 · Journal of Medicinal Chemistry
BRADSHAW: a system for automated molecular design
Darren V. S. Green, Stephen D. Pickett, Chris N. Luscombe, Stefan Senger, David Marcus, Jamel Eddine Meslamani, David Brett, Adam Powell, Jonathan Masson · 2019 · Journal of Computer-Aided Molecular Design
Mechanism-based Fluorescent Labeling of β-Galactosidases
Masaki Kurogochi, Shin‐Ichiro Nishimura, Yuan Chuan Lee · 2004 · Journal of Biological Chemistry
Inhibition of sialidase activity as a therapeutic approach
Glanz, Victor Yu, Myasoedova, Veronika A, Grechko, Andrey V, Orekhov, Alexander N · 2018 · Drug Design Development and Therapy
Current and novel antiviral strategies for influenza infection
Hui‐Ling Yen · 2016 · Current Opinion in Virology
Antiviral therapy of influenza
Janet A. Englund · 2002 · Seminars in Pediatric Infectious Diseases
Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
T Nishikawa, Kazufumi Shimizu, Torahiko Tanaka, Kazumichi Kuroda, Tadatoshi Takayama, Tatsuo Yamamoto, Nobuhiro Hanada, Yoshiki Hamada · 2012 · PLoS ONE
A Practical and Azide-Free Synthetic Approach to Oseltamivir from Diethyl d -Tartrate
Jiang Weng, Yong-Bo Li, Ruibin Wang, Feng-Quan Li, Can Liu, Albert S. C. Chan, Gui Lu · 2010 · The Journal of Organic Chemistry
Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells
Dhamayanthi Pugazhendhi, Kimberly A. Watson, Sarah E. E. Mills, Nigel P. Botting, Gerald S. Pope, Philippa D. Darbre · 2008 · Journal of Endocrinology
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds
Susan Lepri, Giulio Nannetti, Giulia Muratore, Gabriele Cruciani, Renzo Ruzziconi, Beatrice Mercorelli, Giorgio Palù, Arianna Loregian, Laura Goracci · 2014 · Journal of Medicinal Chemistry
Scaffold Hopping in De Novo Design. Ligand Generation in the Absence of Receptor Information
David G. Lloyd, Christoph Lars Buenemann, Nikolay P. Todorov, David T. Manallack, Philip M. Dean · 2003 · Journal of Medicinal Chemistry
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
David Jackson, William Barclay, Thomas Zürcher · 2005 · Journal of Antimicrobial Chemotherapy
Management of Influenza Virus Infections with Neuraminidase Inhibitors
Jennifer L. McKimm‐Breschkin · 2005 · Treatments in Respiratory Medicine
Combination Chemotherapy for Influenza
Elena A. Govorkova, Robert G. Webster · 2010 · Viruses
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir
Mariana Baz, Yacine Abed, Guy Boivin · 2006 · Antiviral Research
Solid-phase extraction on C18 silica as a purification strategy in the solution synthesis of a 1-thio-β-d-galactopyranoside library
Ulf J. Nilsson, Eric J.-L. Fournier, Ole Hindsgaul · 1998 · Bioorganic & Medicinal Chemistry
Rapid determination of the binding affinity and specificity of the mushroom Polyporus squamosus lectin using frontal affinity chromatography coupled to electrospray mass spectrometry
B. Zhang, Monica M. Palcic, Hanqing Mo, I. J. Goldstein, Ole Hindsgaul · 2001 · Glycobiology
Antiviral Drugs Against Alphaherpesvirus
Kimiyasu Shiraki · 2018 · Advances in experimental medicine and biology
Robust QSAR Models from Novel Descriptors and Bayesian Regularised Neural Networks
David Alan Winkler, Frank R. Burden · 2000 · Molecular Simulation
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus
Qi-Shi Du, Shuqing Wang, Kuo‐Chen Chou · 2007 · Biochemical and Biophysical Research Communications
Effects of the Neuraminidase Inhibitor Zanamivir on Otologic Manifestations of Experimental Human Influenza
Jeffrey B. Walker, Elizabeth K. Hussey, John J. Treanor, Alfred Montalvo, Jr., Frederick G. Hayden · 1997 · The Journal of Infectious Diseases
1H NMR in the structural and conformational analysis of oligosaccharides and glycoconjugates
Elizabeth F. Hounsell · 1995 · Progress in Nuclear Magnetic Resonance Spectroscopy
MANAGING INFLUENZA: AMANTADINE, RIMANTADINE AND BEYOND
DM Fleming · 2001 · International Journal of Clinical Practice
Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in Mammals
Ирина Анатольевна Ленева, Olga G. Goloubeva, Robert J. Fenton, Margaret Tisdale, Robert G. Webster · 2001 · Antimicrobial Agents and Chemotherapy
QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα
Feroz Khan, Sarfaraz Alam · 2014 · Drug Design Development and Therapy
Inhibitory Effect and Possible Mechanism of Action of Patchouli Alcohol against Influenza A (H2N2) Virus
Huaxing Wu, Beili Li, Xue Wang, Mingyuan Jin, Guonian Wang · 2011 · Molecules
Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives
Takeshi Honda, Takeshi Masuda, Shuku Yoshida, Masami Arai, Yoshiyuki Kobayashi, Makoto Yamashita · 2002 · Bioorganic & Medicinal Chemistry Letters
Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase
Louise M. Birch, Christopher W. Murray, Michael J. Hartshorn, Ian J. Tickle, Marcel L. Verdonk · 2002 · Journal of Computer-Aided Molecular Design
Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza
William B Dreitlein, Julia Maratos, Joseph M. Brocavich · 2001 · Clinical Therapeutics
Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site 1 1Edited by I. A. Wilson
James B. Finley, Venkatram R. Atigadda, Franco J. Duarte, James J Zhao, Wayne J. Brouillette, Gillian M. Air, Ming Luo · 1999 · Journal of Molecular Biology
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses
Wen‐Hsien Wen, Shiyun Wang, Keng‐Chang Tsai, Yih‐Shyun E. Cheng, An‐Suei Yang, Jim‐Min Fang, Chi‐Huey Wong · 2010 · Bioorganic & Medicinal Chemistry
Direct Measurement of the Anti-Influenza Agent Zanamivir in the Respiratory Tract following Inhalation
Amy Peng, Stefano Milleri, Daniel S. Stein · 2000 · Antimicrobial Agents and Chemotherapy
Three- and four-body corrected fragment molecular orbital calculations with a novel subdividing fragmentation method applicable to structure-based drug design
Chiduru Watanabe, Kaori Fukuzawa, Yoshio Okiyama, Takayuki Tsukamoto, Akifumi Kato, Shigenori Tanaka, Yuji Mochizuki, Tatsuya Nakano · 2013 · Journal of Molecular Graphics and Modelling
Structure of the Ligand-blocked Periplasmic Entrance of the Bacterial Multidrug Efflux Protein TolC
Matthew K. Higgins, Jeyanthy Eswaran, Patricia C. Edwards, Gebhard F. X. Schertler, Colin Hughes, Vassilis E. Koronakis · 2004 · Journal of Molecular Biology
An Expeditious Synthesis of Sialic Acid Derivatives by Copper(I)-Catalyzed Stereodivergent Propargylation of Unprotected Aldoses
Xiaofeng Wei, Y. Shimizu, Motomu Kanai · 2016 · ACS Central Science
Potent Inhibition of Influenza Sialidase by a Benzoic Acid Containing a 2-Pyrrolidinone Substituent
Venkatram R. Atigadda, Wayne J. Brouillette, Franco J. Duarte, Shoukath M. Ali, Yarlagadda S. Babu, Shanta Bantia, Pooran Chand, Naiming Chu, John A. Jr. Montgomery, David Andrew Walsh et al. · 1999 · Journal of Medicinal Chemistry
Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors
Clarence J. Maring, Vincent S. Stoll, Chen Zhao, Minghua Sun, A. Chris Krueger, Kent D. Stewart, Darold L. Madigan, Warren M. Kati, Yibo Xu, Robert J. Carrick et al. · 2005 · Journal of Medicinal Chemistry
Lennard-Jones Potential and Dummy Atom Settings to Overcome the AUTODOCK Limitation in Treating Flexible Ring Systems
Forli, Stefano, Botta, Maurizio · 2007 · Journal of Chemical Information and Modeling
Computer-Aided Drug Design
Prasad V. Bharatam · 2021 · Springer eBooks
The environmental fate of the antiviral drug oseltamivir carboxylate in different waters
Peter Bartels, Wolf von Tümpling · 2008 · The Science of The Total Environment
Structural Basis for Streptococcus pneumoniae NanA Inhibition by Influenza Antivirals Zanamivir and Oseltamivir Carboxylate
H. Gut, Guogang Xu, Garry L. Taylor, Martin Austin Walsh · 2011 · Journal of Molecular Biology
Influenza A Virus N5 Neuraminidase Has an Extended 150-Cavity
Mingyang Wang, Jianxun Qi, Yue Liu, Christopher John Vavricka, Yan Wu, Qing Li, George F. Gao · 2011 · Journal of Virology
Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection
Kazuya I.P.J. Hidari, Takeomi Murata, Kazuhiro Yoshida, Yoshimasa Takahashi, Yohei Minamijima, Y. Miwa, Satoshi Adachi, Makoto Ogata, Taichi Usui, Yasuo Suzuki et al. · 2008 · Glycobiology
Creating a structural genomics consortium.
Alan R. Williamson · 2000 · Nature Structural Biology
Flexible Synthesis and Biological Activity of Uronic Acid-Type gem-Diamine 1-N-Iminosugars: A New Family of Glycosidase Inhibitors
Yoshio Nishimura, Eiki Shitara, Hayamitsu Adachi, Minako Toyoshima, Motowo Nakajima, Yoshirō Okami, TOMIO TAKEUCHI · 1999 · The Journal of Organic Chemistry
Cyclic Amidine Sugars as Transition-State Analogue Inhibitors of Glycosidases: Potent Competitive Inhibitors of Mannosidases
Marie‐Pierre Heck, Stéphane P. Vincent, Brion William Murray, F. D. BELLAMY, Chi‐Huey Wong, Charles Mioskowski · 2004 · Journal of the American Chemical Society
Oseltamivir: a clinical and pharmacological perspective
Fred Y. Aoki, Karen Elizabeth Doucette · 2001 · Expert Opinion on Pharmacotherapy
John F. Enders Lecture 2006: Antivirals for Influenza
Adrian Ong, Frederick G. Hayden · 2007 · The Journal of Infectious Diseases
Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase
Vanessa Leiria Campo, Renata Sesti‐Costa, Zumira A. Carneiro, João S. Silva, Sérgio Schenkman, Ivone Carvalho · 2011 · Bioorganic & Medicinal Chemistry
Antivirals--current trends in fighting influenza.
Ewelina Król, Malgorzata Rychłowska, Bogusław Szewczyk · 2014 · Acta Biochimica Polonica
Assembly of Subtype 1 Influenza Neuraminidase Is Driven by Both the Transmembrane and Head Domains
Diogo V. da Silva, Johan Nordholm, Ursula Madjo, Annika Pfeiffer, Robert Daniels · 2012 · Journal of Biological Chemistry
Synthesis and Influenza Virus Inhibitory Activities of Carbosilane Dendrimers Peripherally Functionalized with Hemagglutinin-Binding Peptide
Ken Hatano, Teruhiko Matsubara, Yosuke Muramatsu, Masakazu Ezure, Tetsuo Koyama, Koji Matsuoka, Ryunosuke Kuriyama, Haruka Kori, Toshinori Sato · 2014 · Journal of Medicinal Chemistry
Affinity scale between a carrier and a drug in DPI studied by atomic force microscopy
Véronique Bérard, Éric Lesniewska, C Andrès, D Pertuy, C Laroche, Yvette Pourcelot · 2002 · International Journal of Pharmaceutics
Characterization of 2 Influenza A(H3N2) Clinical Isolates with Reduced Susceptibility to Neuraminidase Inhibitors Due to Mutations in the Hemagglutinin Gene
Yacine Abed, Anne–Marie Bourgault, Robert J. Fenton, Peter J. Morley, David Gower, Ian J. Owens, Margaret Tisdale, Guy Boivin · 2002 · The Journal of Infectious Diseases
Inhibition of Parainfluenza Virus Type 3 and Newcastle Disease Virus Hemagglutinin-Neuraminidase Receptor Binding: Effect of Receptor Avidity and Steric Hindrance at the Inhibitor Binding Sites
Matteo Porotto, Matthew T. Murrell, Olga Greengard, Michael C. Lawrence, Jennifer L. McKimm‐Breschkin, Anne Moscona · 2004 · Journal of Virology
Human Parainfluenza Virus Type 3 HN-Receptor Interaction: Effect of 4-Guanidino-Neu5Ac2en on a Neuraminidase-Deficient Variant
Matteo Porotto, Olga Greengard, Natalia Poltoratskaia, Maria-Arantxa Horga, Anne Moscona · 2001 · Journal of Virology
Deposition and Disposition of [C]Zanamivir Following Administration as an Intranasal Spray
Mats Bergström, Lindsey Cass, S. Valind, Göran Westerberg, Eva-Lise Lundberg, Steven Gray, Alan Bye, Bengt Långström · 1999 · Clinical Pharmacokinetics
Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza
Nicolas Widmer, Pascal R. Meylan, Anton Ivanyuk, Manel Aouri, Laurent Arthur Decosterd, Thierry Buclin · 2010 · Clinical Pharmacokinetics
Synergistic Effect of Zanamivir−Porphyrin Conjugates on Inhibition of Neuraminidase and Inactivation of Influenza Virus
Wen‐Hsien Wen, Meng‐I Lin, Ching‐Yao Su, Shiyun Wang, Yih‐Shyun E. Cheng, Jim‐Min Fang, Chi‐Huey Wong · 2009 · Journal of Medicinal Chemistry
Catalytic Asymmetric anti‐Selective Nitroaldol Reaction En Route to Zanamivir
Tatsuya Nitabaru, Naoya Kumagai, Masakatsu Shibasaki · 2012 · Angewandte Chemie International Edition
Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir
Takeshi Masuda, Satoshi Shibuya, Masami Arai, Shuku Yoshida, Takanori Tomozawa, Akiko Ohno, Makoto Yamashita, Takeshi Honda · 2003 · Bioorganic & Medicinal Chemistry Letters
A simple method for the preparation of thioglycosides ofN-acetylneuraminic acid
Simon Bennett, Mark von Itzstein, Milton J. Kiefel · 1994 · Carbohydrate Research
Structure-Based Design and Synthesis of C-1- and C-4-Modified Analogs of Zanamivir as Neuraminidase Inhibitors
Enguang Feng, Woo-Jin Shin, Xuelian Zhu, Jian Li, Deju Ye, Jiang Wang, Mingyue Zheng, Jianping Zuo, Kyoung Tai No, Xian Liu et al. · 2013 · Journal of Medicinal Chemistry
Engineering of an N-acetylneuraminic acid synthetic pathway in Escherichia coli
Junhua Kang, Pengfei Gu, Yang Wang, Yikui Li, Fan Yang, Qian Wang, Qingsheng Qi · 2012 · Metabolic Engineering
A review of neuraminidase inhibitor susceptibility in influenza strains
Nick E. Spanakis, Vassiliki Ch. Pitiriga, Vassiliki Gennimata, Athanasios Tsakris · 2014 · Expert Review of Anti-infective Therapy
Design, synthesis and biological evaluation of novel l-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors
Han Wang, Renyang Xu, Yongying Shi, Longlong Si, Pingxuan Jiao, Zibo Fan, Han Xu, Xingyu Wu, Xiaoshu Zhou, Fei Yu et al. · 2016 · European Journal of Medicinal Chemistry
Towards an Optimal Sample Delivery Method for Serial Crystallography at XFEL
Robert Cheng · 2020 · Crystals
Influenza Virus Virulence and Its Molecular Determinants
Diana L. Noah, Robert M. Krug · 2005 · Advances in virus research
Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface.
Paul Digard, Kevin P. Williams, Preston Hensley, Ian S. Brooks, Charles E. Dahl, Donald M. Coen · 1995 · Proceedings of the National Academy of Sciences